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Cells can respond rapidly to changes in their cellular environments such as 
oxygen levels, and transcription factors play a critical role in response to such changes to 
achieve homeostasis. Sterol regulatory element-binding proteins (SREBPs) are 
membrane-bound transcription factors that serve as master regulators of cholesterol and 
fatty acid homeostasis. Mammalian SREBPs are proteolytically activated and liberated 
from the membrane by Golgi Site-1 and Site-2 proteases. However, fission yeast 
SREBPs, Sre1 and Sre2, employ a different mechanism that genetically requires the 
Golgi defective for SREBP cleavage (Dsc) E3 ligase complex for cleavage activation.  
In this thesis, I defined structural requirements for fission yeast SREBP cleavage. 
I isolated a collection of cleavage mutants in Sre2 C-terminus and identified a novel 
SREBP cleavage motif, the glycine-leucine motif. I revealed an extensive conservation of 
this motif in at least 20 SREBP homologs of ascomycete fungi using defined 
bioinformatic criteria, including the human opportunistic pathogen Aspergillus 
fumigatus and Candida albicans where SREBPs are required for fungal pathogenesis. I 
also demonstrated functional conservation of this motif in Sre1 as required for adaptation 
to low oxygen. Further, I identified potential mechanisms for degradation of Sre2 C-
terminus by the Dsc E3 ligase and the proteasome. Importantly, I have established Sre2 
as the first physiological substrate for dissecting Golgi E3 ligase-dependent protein 
processing. Therefore, Sre2 can serve as a model substrate and gateway for understanding 
Golgi protein degradation and processing. Further study into the mechanism of Dsc E3 
ligase-dependent SREBP processing entails broad implications for cellular adaptation to 
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low oxygen and sterol conditions and may enable the development of novel antifungal 
therapeutics. 
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Cells must be able to respond rapidly to changes in their cellular environments 
such as chemicals, gases and macromolecules. Transcription factors play a critical role in 
response to such changes to maintain homeostasis. Sterol Regulatory Element-Binding 
Proteins (SREBPs) are membrane-bound transcription factors that serve as master 
regulators of cholesterol and fatty acid synthesis in mammals (Brown and Goldstein, 
1998). Recent research from our group and others has expanded the roles of SREBPs 
beyond sterol regulation and beyond the mammalian system (Bien and Espenshade, 2010; 
Hughes et al., 2005; Shao and Espenshade, 2012). In this chapter, I sought to provide a 
brief history of SREBPs, as well as highlight recent advances in our understanding of 
SREBP cleavage in fungi, and its implications for hypoxic adaptation, protein quality 













Mammalian SREBP pathway 
Cellular lipid homeostasis is regulated by a class of transcription factors 
designated sterol regulatory element-binding proteins (SREBPs) (Figure 1.1) (Brown and 
Goldstein, 1998). In the human genome, two genes code for the three SREBP isoforms: 
SREBP-1a, SREBP-1c and SREBP-2, which belong to a subfamily of basic helix-loop-
helix (bHLH) leucine zipper proteins. SREBP-1a regulates all SREBP target genes, while 
SREBP-1c and SREBP-2 preferentially regulate genes required for fatty acid and 
cholesterol synthesis respectively (Espenshade and Hughes, 2007). To activate target 
gene expression, the SREBP-Scap complex is transported via COPII vesicles from the 
endoplasmic reticulum (ER) to Golgi (Figure 1.1). In mammalian cells, following sterol-
regulated transport to the Golgi, SREBPs are activated through sequential cleavage by the 
Golgi-resident Site-1 protease and Site-2 protease (Figure 1.1) (Brown and Goldstein, 
1997, 1999a).  
Specifically, Site-1 protease cleaves in the SREBP lumenal loop, splitting the 
molecule in half. This first cleavage event enables the Site-2 protease zinc 
metalloprotease to cleave within the first transmembrane segment (TM1) and release the 
soluble SREBP N-terminal transcription factor from the membrane (Rawson et al., 1997).  
Mammalian SREBP is cleaved sequentially by the Site-1 protease in the ER lumenal 
loop, before it can be cleaved by the Site-2 protease within TM1 to release functional 
transcription factor domain (Brown and Goldstein, 1999b).  
Site-1 protease belongs to the subtilisin/kexin-like protease family, required for 
cleaving many proproteins to their active form (Seidah, 2011; Seidah et al., 1998). 
Subtilisin/kexin-like proteases typically cleave after lysine or arginine and dibasic 
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sequences (Seidah, 2011; Seidah et al., 1998). Cleavage of mammalian SREBP-2 by Site-
1 protease occurs at a lumenal RXXL sequence, which in the case of human SREBP-2 
cleavage occurs at a leucine-serine bond in the ER lumen (Duncan et al., 1997). More 
generally, proteases in the subtilisin/kexin-like family cleave after the consensus R-X-
(R/K)-R sequence, where X is any amino acid except cysteine (Steiner, 1998).  
Following Site-1 protease cleavage, Site-2 protease (S2P) cleaves SREBP-2 at a 
membrane-embedded leucine-cysteine bond (Duncan et al., 1998). Further domain-
swapping studies reveal a cleavage requirement for an asparagine-proline sequence in the 
middle third of the transmembrane segment (Ye et al., 2000b). The mechanism by which 
the asparagine-proline sequence facilitates SREBP-2 cleavage is not known, but the 
favored model suggests a possible conformational change of the SREBP-2 to unwind the 
transmembrane alpha-helix for access to Site-2 protease (Ye et al., 2000a). In mammals, 
S2P is essential for membrane release and SREBP activity. This S2P-mediated 
intramembrane cleavage is an example of regulated intramembrane proteolysis (RIP), 
with the transcription factor ATF6 demonstrated to be another substrate of S2P 









Fungal SREBP pathway 
The criteria for definition of SREBPs as transcription factors lie in the two 
predicted transmembrane segments and the unique tyrosine residue in the bHLH DNA 
binding domain (Figure 1.2). Based on these criteria, SREBPs are also conserved in 
diverse fungi in addition to animals, but not in bacteria, plant or archaea kingdoms 
(Figure 1.3). SREBP is conserved in both Basidiomycota and Ascomycota, the two major 
fungal phyla. It is interesting that under Ascomycota phylum, SREBP is conserved in the 
fission yeast Schizosaccharomyces pombe but not the more popular model organism 
budding yeast Saccharomyces cerevisiae (Figure 1.3). Thus, our group chose to establish 
the fission yeast as a model to understand SREBP proteolytic activation and regulation in 
fungi.  
Insights from this simple single-celled eukaryote can be gleaned and translated to 
a more physiologically relevant organism to human health, such as cultured mammalian 
cells. Studies from our group thus far have revealed novel modes of regulation for 
SREBP in fission yeast: at the level of regulated SREBP cleavage, protein stability post-
SREBP cleavage, and modeling the SREBP feedback loops upon signal sensing (Lee et 
al., 2007; Stewart et al., 2012; Stewart et al., 2011; Porter et al., 2012; Porter et al., 2010). 







Fission yeast SREBPs 
Fission yeast Schizosaccharomyces pombe contains two SREBP homologs: Sre1 
and Sre2 (Figure 1.2). Sre1 is an oxygen-regulated transcription factor that is cleaved 
under low oxygen to promote adaptation to hypoxia (Hughes et al., 2005). Sre1, like the 
mammalian counterpart, contains a C-terminal domain that binds to Scp1, the homolog of 
mammalian Scap that also senses sterol levels (Hughes et al., 2008; Hughes et al., 2005). 
In this system, Sre1 senses oxygen by regulated Scp1 binding as a surrogate for cellular 
sterol level, because sterol production is highly oxygen consumptive (Hughes et al., 
2005; Todd et al., 2006). In contrast, Sre2 lacks the C-terminal regulatory domain and 
bypasses sterol or oxygen regulation for cleavage; therefore, Sre2 cleavage occurs in the 
presence of oxygen, and is constitutive and unregulated (Hughes et al., 2005). Fission 
yeast, like all other ascomycete fungi, lacks an identifiable Site-2 protease homolog 
(Figure 1.4), suggesting a different mechanism for SREBP cleavage (Espenshade and 
Hughes, 2007).  
Genetic evidence revealed that both Sre1 and Sre2 cleavage requires a multi-
subunit Golgi-resident E3 ligase, which we named Dsc (defective for SREBP cleavage) 
(Stewart et al., 2012; Stewart et al., 2011). The Dsc E3 ligase, composed of Dsc1 through 
Dsc5, is a stable membrane complex containing the RING-domain E3 ubiquitin ligase 
Dsc1 (Stewart et al., 2012). The Dsc E3 ligase contains structural domains involved in 
the ubiquitin/proteasome system (UPS), and is analogous to its homologs in budding 
yeast and mammalian cells (Lloyd et al., 2013). This parallel is strengthened by 
additional genetic studies for genes required for yeast SREBP cleavage, which revealed 
dsc5 and dsc6. Dsc6 codes for Cdc48, an AAA-ATPase that binds to the Dsc E3 ligase 
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through the ubiquitin regulatory X (UBX) domain of Dsc5 (Stewart et al., 2012). 
Previous studies indicate that the mechanism of cleavage is the same for Sre1 and Sre2 
(Stewart et al., 2012; Stewart et al., 2011), except that ER exit of Sre1 is regulated by 
sterols and oxygen and Sre2 exits the ER constitutively (Hughes et al., 2005; Porter et al., 
2012).  
Our working model for Sre1 cleavage is as follows (Figure 1.5): (1) Sre1 moves 
from the ER to Golgi under low oxygen or sterol conditions; (2) Sre1 binds to the Dsc E3 
ligase; (3) SREBP is ubiquitinated by the E2 ubiquitin-conjugating enzyme Ubc4 and E3 
ligase Dsc1; (4) SREBP is subsequently cleaved by an unidentified protease releasing the 
N-terminal transcription factor domain from the membrane.  
 
Dsc E3 ligase: role in Golgi protein degradation 
The ability of the cell to maintain constant flux of cargo proteins and segregation 
of misfolded proteins in the secretory pathway is termed “protein quality control” 
(Ellgaard and Helenius, 2003). These processes serve to remove defective proteins that 
might otherwise be detrimental to the health and viability of eukaryotic cells. Dsc E3 
ligase represents a potential protein machine for Golgi protein quality control or 
degradation, because it is homologous to the Hrd1 and mammalian gp78 E3 ligases that 
participate in ER-associated degradation (ERAD), a mechanism of ER protein quality 
control (Smith et al., 2011). In detail, the Dsc complex contains a RING domain 
containing protein Dsc1, a ubiquitin-associated (UBA) domain-containing rhomboid 
pseudoprotease Dsc2, as well as a UBX-domain containing protein Dsc5 (Stewart et al., 
2012; Stewart et al., 2011).  These structural domains are analogous in their subunit 
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architecture to the budding yeast ERAD components Hrd1, Der1 and Ubx2 respectively 
(Bays et al., 2001), and the mammalian ERAD components gp78, UBAC2 and UBXD8 
respectively (Christianson et al., 2012). 
In ERAD, transmembrane multi-subunit E3 ligases recognize and ubiquitinate 
misfolded or mutant proteins in the ER, which are then targeted for degradation by the 
proteasome. Subsequently, the AAA-ATPase Cdc48 or its mammalian counterpart p97 is 
then responsible for subsequent membrane protein extraction and degradation (Stolz et 
al., 2011). Importantly, in both budding and fission yeast, aggravating genetic 
interactions exist between Dsc E3 ligase and multivesicular body pathway components, 
suggesting that Dsc E3 ligase may participate in post-ER protein degradation/processing 
(Henne et al., 2011; Stewart et al., 2011). Finally, the Dsc E3 ligase is also conserved in 
budding yeast. Tul1 is the homolog for Dsc1 in S. pombe, and has been shown to be 
responsible for recognition of a mutant carboxypeptidase that has a charged residue in the 
transmembrane segment and its sorting into multivesicular bodies (Reggiori and Pelham, 
2002). SREBPs are absent in budding yeast (Figure 1.3), further arguing for a post-ER 
protein quality control function of Dsc E3 ligase beyond SREBP cleavage.  
 
SREBP pathway and fungal pathogenesis 
Fungal pathogens remain detrimental to human health and agriculture. To date, 
fungal SREBPs have also been characterized in the human pathogens Cryptococcus 
neoformans and Aspergillus fumigatus (Chang et al., 2007; Chun et al., 2007; Hughes et 
al., 2005; Lee et al., 2007; Osborne and Espenshade, 2009; Willger et al., 2008). 
Aspergillus fumigatus is a major cause of life-threatening infections in 
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immunocompromised individuals (Latge, 1999). Notably, Aspergillus fumigatus SREBP 
homolog SrbA as well as Dsc E3 ligase homologs are required for pathogenesis (Willger 
et al., 2012; Willger et al., 2008). Our group has also revealed C. neoformans Sre1 as 
required for regulating ergosterol biosynthesis (Chang et al., 2007), as well as a role for 
C. neoformans Site-2 protease for C. neoformans Sre1 cleavage and subsequent fungal 
pathogenesis (Bien et al., 2010). In addition, we have recently identified a putative 
SREBP homolog called Cph2 in the ascomycete fungal pathogen Candida albicans, 
which is required for yeast-to-hypha growth transition and virulence (Lane et al., 2001a; 
Lane et al., 2001b). Collectively, these studies revealed that fungal SREBPs are 
transcription factors required for fungal pathogenesis (Bien and Espenshade, 2010). In 
terms of plant pathogens, the fungal rice blast pathogen Magnaporthe oryzae, which 
causes destructive rice diseases and crop losses worldwide (Wilson and Talbot, 2009), 
also contains a putative SREBP homolog. Because many other pathogenic fungi contain a 
SREBP pathway, study of the molecular underpinnings of SREBP cleavage activation 











My work in the Espenshade lab followed the discovery of the Dsc E3 ligase 
complex as genetically required for fission yeast SREBP cleavage activation. At this 
stage, the mechanism of how the Dsc E3 ligase mediates cleavage and the responsible 
fungal protease remains unknown. In my thesis work, I sought to establish Sre2 as a 
model to understand the yeast SREBP cleavage mechanism using a two-pronged 
approach: (1) from the substrate perspective, I defined the structural requirements for 
fission yeast SREBP cleavage; (2) I monitored the post-cleavage fate of the SREBP C-
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Figure 1.1    The mammalian SREBP pathway. 
When sterol levels are high, the SREBP-Scap complex is retained in the endoplasmic 
reticulum (ER) by binding to INSIG. Under sterol deplete conditions, SREBP-Scap is 
transported to the Golgi apparatus where SREBP is sequentially cleaved by the Golgi 
Site-1 protease (S1P) and Site-2 protease (S2P). Soluble SREBP N-terminus then enters 
the nucleus and activates genes required for lipid synthesis and uptake. 
 
Figure 1.2    Schizosaccharomyces pombe homologs of mammalian SREBP. 
Transmembrane helix prediction plots of human SREBP-1a and Schizosaccharmyces 
pombe homologs Sre1 and Sre2. These predictions are generated using the TM-HMM 2.0 
software. Heavy bars denote regions of high sequence identity. The amino acid position 
of the highly conserved tyrosine in the basic helix-loop-helix zipper domain (bHLH-zip) 
is indicated (Adapted from Hughes et al., 2005). 
 
Figure 1.3    SREBP conservation from fungi to mammals. 
Species for which SREBPs are conserved are indicated in blue. SREBPs are conserved 
from fungi to animals, but not in bacteria, plants or archaea kingdom. SREBP is 
conserved in both Basidiomycota and Ascomycota, the two major fungal phyla. 
Representative species are indicated for each phylum. Note that under the Ascomycota 
phylum, SREBP is conserved in the fission yeast Schizosaccharomyces pombe but not the 
budding yeast Saccharomyces cerevisiae. 
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Figure 1.4    SREBP and Site-2 protease conservation from fungi to mammals. 
Species for which SREBPs are conserved are indicated in blue, while species for which 
both SREBP and Site-2 protease are conserved are indicated in red. Note that Site-2 
protease is only conserved in the basidiomycete fungi Cryptococcus neoformans and 
Cropinopsis cinerea, but not in the ascomycete fungi Schizosaccharomyces pombe or 
Aspergillus fumigatus. 
 
Figure 1.5    Sre1 pathway in Schizosaccharomyces pombe. 
Under low oxygen conditions, the S. pombe SREBP Sre1 is transported from 
endoplasmic reticulum (ER) to the Golgi apparatus, where it is proteolytically activated 
by the Dsc E3 ligase complex Dsc1 through Dsc5, E2 ubiquitin conjugating enzyme 
Ubc4 and the AAA-ATPase Cdc48. The soluble N-terminus of Sre1 enters the nucleus 
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This chapter is an edited version of the manuscript, “Structural Requirements for Sterol 
Regulatory Element-Binding Protein (SREBP) Cleavage in Fission Yeast 
” by R. Cheung and P. J. Espenshade, published in the Journal of Biological Chemistry, 
Volume 288, Issue 28, 20351-20360. © 2013 American Society for Biochemistry and 




Sterol regulatory element-binding proteins (SREBPs) are central regulators of 
cellular lipid synthesis and homeostasis. Mammalian SREBPs are proteolytically 
activated and liberated from the membrane by Golgi Site-1 and Site-2 proteases. Fission 
yeast SREBPs, Sre1 and Sre2, employ a different mechanism that genetically requires the 
Golgi Dsc E3 ligase complex for cleavage activation. Here, we established Sre2 as a 
model to define structural requirements for SREBP cleavage. We showed that Sre2 
cleavage does not require the N-terminal basic helix-loop-helix zipper transcription factor 
domain (bHLH-zip), thus separating cleavage of Sre2 from its transcription factor 
function. From a mutagenesis screen of 94 C-terminal residues of Sre2, we isolated 15 
residues required for cleavage and further identified a glycine-leucine sequence required 
for Sre2 cleavage. Importantly, this sequence is located at a conserved distance before the 
first transmembrane segment of both Sre1 and Sre2, and cleavage occurs between this 
sequence and the membrane. Bioinformatic analysis revealed a broad conservation of this 
novel glycine-leucine motif in SREBP homologs of ascomycete fungi, including the 
opportunistic human pathogen Aspergillus fumigatus where SREBP is required for 
virulence. Consistent with this, the sequence was also required for cleavage of the 
oxygen-responsive transcription factor Sre1 and adaptation to hypoxia, demonstrating 
functional conservation of this cleavage recognition motif. These cleavage mutants will 
aid identification of the fungal SREBP protease and facilitate functional dissection of the 





Cellular lipid synthesis and homeostasis are centrally regulated by sterol 
regulatory element-binding protein (SREBP) transcription factors (Espenshade and 
Hughes, 2007; Shao and Espenshade, 2012). These membrane-bound transcription 
factors contain two transmembrane segments and are inserted into the endoplasmic 
reticulum (ER) in a hairpin orientation with the N- and C-termini projecting into the 
cytosol (Espenshade and Hughes, 2007). SREBP N-terminus contains a basic-helix-loop-
helix zipper (bHLH-zip) transcription factor domain that is required for DNA binding and 
transcriptional activation of its target genes required for cholesterol and fatty acid 
synthesis (Espenshade and Hughes, 2007). In mammalian cells following sterol-regulated 
transport to the Golgi, SREBPs are activated through sequential cleavage by the Golgi-
resident Site-1 protease and Site-2 protease. Specifically, Site-1 protease is a 
subtilisin/kexin-like, serine protease that cleaves in the SREBP lumenal loop, splitting the 
molecule in half. This first cleavage event enables the Site-2 protease zinc 
metalloprotease to cleave within the first transmembrane segment (TM1) and release the 
soluble SREBP N-terminal transcription factor from the membrane (Rawson et al., 1997). 
In mammals, S2P is essential for membrane release and SREBP activity. 
Fungal SREBPs have been characterized in Schizosaccharomyces pombe and the 
human pathogens Cryptococcus neoformans and Aspergillus fumigatus (Chang et al., 
2007; Chun et al., 2007; Hughes et al., 2005; Lee et al., 2007; Osborne and Espenshade, 
2009; Willger et al., 2008). Collectively, these studies revealed that fungal SREBPs are 
oxygen-responsive transcription factors required for adaptation to hypoxia and fungal 
pathogenesis (Bien and Espenshade, 2010). Fission yeast Schizosaccharomyces pombe 
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contains two SREBP homologs: Sre1 and Sre2 (Hughes et al., 2005). Sre1 is an oxygen-
responsive transcription factor that is cleaved under low oxygen to promote adaptation to 
hypoxia (Hughes et al., 2005). In contrast, cleavage of the less well-characterized Sre2 
occurs in the presence of oxygen and is unregulated. This feature of Sre2 makes it a 
useful model to study structural requirements for cleavage under routine cell culture 
conditions rather than low oxygen (Stewart et al., 2012; Stewart et al., 2011).  
Fission yeast lacks an identifiable Site-2 protease homolog, suggesting a different 
mechanism for SREBP cleavage (Espenshade and Hughes, 2007). Previously, we showed 
that Sre1 is cleaved at a cytosolic position, instead of within TM1, consistent with Site-2 
protease-independent cleavage. Genetic evidence revealed that both Sre1 and Sre2 
cleavage requires a multi-subunit Golgi-localized E3 ligase, which we named Dsc 
(defective for SREBP cleavage) (Stewart et al., 2012; Stewart et al., 2011). The Dsc E3 
ligase, composed of Dsc1 through Dsc5, is a stable membrane complex containing the 
RING-domain E3 ubiquitin ligase Dsc1 (Stewart et al., 2012). Consistent with its role in 
SREBP activation, Aspergillus fumigatus Dsc E3 ligase is also required for fungal 
virulence (Willger et al., 2012). 
Despite genetic evidence of cleavage requirements for fission yeast SREBPs, the 
mechanism of how the Dsc E3 ligase mediates cleavage and the responsible fungal 
protease remains unknown. To aid uncoupling mechanistic steps of yeast SREBP 
cleavage, we dissected the cleavage mechanism from a substrate perspective. In the 
present study, we defined the structural requirements for Sre2 cleavage using serial 
truncation analysis and a site-directed mutagenesis screen. We isolated 15 single amino 
acid mutations in Sre2 that prevent cleavage. In addition, we identified a conserved, 7-
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amino acid glycine-leucine sequence in Sre2 required for cleavage. Importantly, the 
glycine-leucine sequence was required for Sre1 cleavage, confirming the function of this 
conserved cleavage recognition motif. This motif is broadly conserved across ascomycete 
fungi, whose members lack homologs of the intramembrane-cleaving Site-2 protease 
present in mammals. These findings demonstrate a role for this conserved glycine-leucine 
motif in fungal SREBP cleavage activation, provide tools for dissecting the mechanism 
of SREBP cleavage, and identify the SREBP C-terminus as a target for antifungal therapy 
for pathogenic fungi that contain a relevant conserved SREBP pathway (Blatzer et al., 

















Minimal sequence required for Sre2 cleavage 
Sre2 is a 793 a.a. protein with two transmembrane segments (a.a. 714-737 and a.a. 
749-771) (Figure 2.1A). To determine what region of Sre2 is required for Dsc-dependent 
cleavage, we generated serial N-terminal truncations of Sre2 and assayed cleavage of 
these mutants in whole cell extracts by immunoblotting (Figure 2.1A). To monitor Sre2 
cleavage events, we inserted a 3xFLAG epitope at the N-terminus of Sre2 truncations, 
thereby allowing us to distinguish Sre2 precursor from Sre2 N-terminal cleaved form. 
Deletion of the N-terminal half of Sre2, a.a. 1-422, had no effect on cleavage. N-terminal 
truncated Sre2 (a.a. 423-793) showed a cleavage pattern similar to full-length Sre2 
(Stewart et al., 2011), with the majority of Sre2 in the cleaved form at steady state 
(Figure 2.1B, lane 1). Importantly, this cleavage required Dsc1 (Figure 2.1B, lane 2), the 
Golgi E3 ligase required for the cleavage activation of both Sre1 and Sre2 precursors 
(Stewart et al., 2011). This result indicated that cleavage does not require Sre2 a.a. 1-422.  
Further Sre2 truncations across the bHLH-zip domain (a.a. 426-516) demonstrated that 
this domain is also not required for cleavage (Figure 2.1B, lanes 3 and 5), despite the 
requirement of this domain for DNA binding and transcription factor activity. Thus, the 
functions of Sre2 as a transcription factor and a substrate for Dsc-dependent cleavage are 
separable. Finally, Sre2 failed to cleave when we truncated Sre2 to a.a. 588 and the Sre2 
precursor migrated at the same position in the presence or absence of dsc1 (Figure 2.1B, 
lanes 7 and 8). Taken together, these results suggest that a.a. 1-522 including the bHLH-
zip domain of Sre2 are not required for cleavage. However, sequences in the C-terminal 
portion of Sre2 are important for cleavage. 
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Cleavage of Sre2 occurs in the cytosol 
Dsc-dependent cleavage of the oxygen-regulated Sre1 transcription factor occurs 
in the cytosol at a position ~10 amino acids before the first transmembrane segment 
(Stewart et al., 2011). Next, we mapped the cleavage site for Sre2. Because Sre2 cleavage 
occurs at a site close to its C-terminus, Sre2 precursor and its cleaved nuclear form are 
not readily resolved by SDS-PAGE. Therefore, we chose to use an Sre2 model substrate, 
Sre2 a.a. 423-793 (hereafter, Sre2-MS), that is efficiently cleaved in a Dsc-dependent 
manner to analyze Sre2 sequences required for cleavage (Figure 2.1B, lanes 1-2). We 
verified that the N-terminus of GFP-Sre2 a.a. 423-793 translocates to the nucleus, 
demonstrating that Sre2-MS is functionally imported after Dsc-dependent cleavage (data 
not shown). These data are consistent with studies on mammalian SREBP-2 showing that 
the bHLH-zip domain functions as a nuclear import signal (Lee et al., 2003). 
Cleavage of mammalian SREBPs by S2P occurs within the first transmembrane 
segment between a leucine and cysteine residue, both of which are not present in Sre2 
(Duncan et al., 1997). To estimate the position of Sre2 cleavage, we generated two C-
terminal truncations of Sre2-MS encoding a.a. 423-697 and 423-712. These two size 
standards truncated Sre2-MS at cytosolic positions prior to the first transmembrane 
segment (Figure 2.1A). Cleaved Sre2-MS migrated between the two C-terminal 
truncations (Figure 2.2A, lane 4). Thus, Sre2 is cleaved between a.a. 697 and 712 in the 
cytosol, consistent with cytosolic cleavage of Sre1 (Stewart et al., 2011). Notably, the 
cytosolic cleavage sites of Sre1 and Sre2 are equidistant (~10 amino acids) from their 
respective first transmembrane segments. These results reinforce the observation that 
SREBP cleavage in S. pombe is mechanistically distinct from that in mammals, whereby 
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cleavage occurs within the first transmembrane segment.  
 
Cleavage of Sre2 model substrate requires Dsc E3 ligase complex, Cdc48 and E2 
enzyme Ubc4 
Cleavage of Sre1 and Sre2 requires each of the subunits of the Golgi Dsc E3 
ligase complex Dsc1 through Dsc5, AAA-ATPase Cdc48 and the E2 ubiquitin-
conjugating enzyme Ubc4 (Stewart et al., 2012; Stewart et al., 2011). To investigate 
whether cleavage requirements of Sre2-MS parallel those of Sre1 and Sre2, we assayed 
cleavage of Sre2-MS in cells lacking each of these components. We found that Dsc1 
through Dsc4 were strictly required for Sre2-MS cleavage (Figure 2.2B, lanes 2-5). In 
dsc5Δ cells, a small amount of Sre2-MS cleaved form was detectable (Figure 2.2B, lane 
6), consistent with partial requirement of dsc5 for cleavage of full length Sre2 precursor 
(Stewart et al., 2012). cdc48-4 contains a mutation (E325K) that lies in the Walker B 
motif in the AAA-ATPase domain of Cdc48 (Stewart et al., 2012). This mutation causes 
a complete block of Sre2 cleavage compared to other cdc48 mutant alleles identified in a 
previous genetic screen, such as cdc48-2 (A586V) and cdc48-3 (E731K) in the D2 
domain of Cdc48, that cause a severe impairment but not complete block (Stewart et al., 
2012). Consistent with this, Sre2-MS cleavage was blocked completely in cdc48-4 
(Figure 2.2B, lane 7) but not in cdc48-2 and cdc48-3 (data not shown). Finally, a 
temperature-sensitive allele ubc4-P61S of the essential E2 enzyme Ubc4 was utilized to 
test its role in Sre2-MS cleavage. Upon shifting to non-permissive temperature to block 
Ubc4 function, the precursor form of Sre2-MS accumulated in ubc4-P61S, but not wild-
type cells (Figure 2.2C). This result indicated that Sre2-MS cleavage requires Ubc4. 
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Taken together, these results demonstrate that Sre2-MS shares all functional requirements 
for Dsc-dependent cleavage with full-length Sre2 (a.a. 1-793) and Sre1 (Stewart et al., 
2012; Stewart et al., 2011), and thus is a model substrate for further mutational studies.  
 
Site-directed mutagenesis screen of Sre2 model substrate 
To understand comprehensively the requirements for Sre2 cleavage, we set out to 
screen for cleavage defects by site-directed scanning mutagenesis of Sre2-MS. Based on 
protein secondary structure prediction programs for structured regions, and given that 
cleavage of both Sre1 and Sre2 occurs close to the first transmembrane segment, we 
focused our studies on the C-terminal 117 amino acids of Sre2-MS, mutating residues 
677-793 (Figure 2.3A). First, we tested a total of 94 amino acid residues by mutating 
amino acids either in single, double or triple mutants (Table 2.S1). We chose not to 
mutate hydrophobic residues in the transmembrane segments as these would likely not be 
well expressed. Mutants were grouped into three classes according to cleavage efficiency 
[the ratio of processed form (N) to precursor form (P)] (Table 2.1). 51 mutants showed 
normal cleavage (N>P), 28 showed a defect in cleavage (N≈P), and 15 showed a robust 
block in cleavage (P>N). Examples of each class are shown in Figure 2.3B. For double or 
triple mutants that demonstrated a robust cleavage block (P>N), we further tested 
cleavage requirements by mutating individual amino acids to alanine for cytosolic 
residues and to leucine for residues within the transmembrane segments. For selective 
residues that are structurally similar to alanine or leucine, we mutated amino acids to 
charged residues such as glutamate or threonine. Figure 2.3A and Table 2.1 summarize 
the results of the Sre2-MS mutagenesis screen.  
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From the screen, we identified a short, 7-amino-acid glycine-leucine region 
required for Sre2 cleavage (a.a. 678-684) (Figure 2.3A). Interestingly, this glycine-
leucine stretch is present in Sre1 (Figure 2.4A) and is roughly equidistant from the first 
transmembrane segment in both Sre1 and Sre2 (27 and 29 amino acids, respectively). 
These observations suggested a role for the glycine-leucine region in Sre2 cleavage. To 
investigate whether this conserved sequence (a.a. 678-684) was required for cleavage, we 
assayed cleavage of single residue mutants. Notably, mutating 5 out of 7 residues blocked 
cleavage when tested individually (Figure 2.4B, lanes 3-7).  
In addition, we identified 10 other single residues required for cleavage (Figure 
2.3A). Two residues, M704 and S705, are located ~10 amino acids before the first 
transmembrane segment close to the cleavage site (Figure 2.4C, lanes 3-12). We 
identified only a single residue, K743, required for cleavage in the short endoplasmic 
reticulum lumenal loop of Sre2. Mutation of 5 residues in the second transmembrane 
segment blocked cleavage (E755, S765, P767, D770, W771) while none in the first 
transmembrane segment were absolutely required (Figure 2.3A). Finally, two charged 
residues in the cytosolic Sre2 C-terminal tail (R778 and E788) were also required for 
cleavage. In total, 15 C-terminal residues were found to be essential for Sre2-MS 
cleavage (Figure 2.3A).  
 
Validation of sequence requirements in full-length Sre2 
To independently test and verify the cleavage requirement for residues identified 
in the Sre2-MS screen, we generated each of the cleavage mutants in full-length Sre2-
GFP. Fusion of GFP to the C-terminus allows clear discrimination between the precursor 
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(P) and cleaved nuclear (N) forms of Sre2 (Stewart et al., 2011). Wild-type Sre2-GFP 
was cleaved constitutively to generate Sre2N and cleavage was blocked in dsc1Δ cells 
(Figure 2.5A, lanes 1-2). Mutation of each of the five glycine-leucine region residues 
blocked cleavage of full-length Sre2-GFP (Figure 2.5A, lanes 3-7), emphasizing the 
importance of this sequence. Indeed, we observed a complete cleavage block for each of 
the additional 10 residues identified using Sre2-MS, examples of which are shown in 
Figure 2.5B. These results validate Sre2 a.a. 423-793 as a model substrate and confirm 
the importance of these 15 residues for cleavage of full-length Sre2. 
As a complementary approach to test the cleavage requirements for individual 
Sre2 residues, we assayed localization of different GFP-Sre2 fusion proteins in cells 
lacking endogenous Sre2. GFP fused to the N-terminus of wild-type Sre2 translocated to 
the nucleus after its release from the membrane (left panel of Figure 2.5C). Failure to 
cleave GFP-Sre2 in dsc1∆ cells caused GFP-Sre2 to localize in punctate structures 
(middle panel of Figure 2.5C) (Stewart et al., 2011). Consistent with a requirement for 
Dsc-dependent cleavage, GFP-Sre2 G683 containing a mutation in the glycine-leucine 
stretch also localized to punctate structures (right panel of Figure 2.5C). We tested all of 
the 15 individual cleavage mutants in this GFP-Sre2 assay and each failed to show 
nuclear localization equivalent to wild-type GFP-Sre2 (data not shown). Combined with 
the full-length Sre2-GFP cleavage assays, these data demonstrate that full-length Sre2 
cleavage requires each of the 15 residues isolated using Sre2-MS, showing the 
physiological importance of these sequences. 
 
 35 
Bioinformatic analysis reveals wide conservation of glycine-leucine motif in 
ascomycete fungi 
Our mutagenesis screen identified a glycine-leucine sequence in Sre2 (a.a. 678-
684) that is required for cleavage and conserved in Sre1 (Figure 2.4A). Interestingly, the 
distance of this sequence from the first transmembrane segment (~30 amino acids) is also 
conserved between Sre2 and Sre1. To investigate whether the glycine-leucine region is 
conserved beyond S. pombe, we searched for glycine-leucine sequences in SREBPs 
ranging from fungi to mammals using a defined set of bioinformatic criteria. Given the 
short length of the conserved sequence, parameter definition was critical for the motif 
search and subsequent consensus motif generation. First, we isolated SREBPs from all 
species by sequence similarity search. We defined SREBPs by the presence of a specific 
tyrosine residue in the first helix of bHLH transcription factors. For each SREBP, we 
predicted coordinates for transmembrane segments using transmembrane prediction 
software, and we used only SREBPs that contained a predicted TM for subsequent 
analysis. Given that the glycine-leucine sequence is located at a conserved distance from 
TM1s of Sre1 and Sre2, we selected a 50-amino-acid stretch that is centered 55 amino 
acids from the beginning of TM1 for each SREBP. We then performed a sequence 
alignment using all isolated 50-amino-acid sequences. In this way, we identified a 
consensus sequence corresponding to the glycine-leucine motif (Figure 2.6A). We 
identified the glycine-leucine motif in all ascomycete fungi analyzed, including 
pathogenic fungi Aspergillus fumigatus and Magnaporthe oryzae, but not basidiomycete 
fungi, like Cryptococcus neoformans (Table 2.S2). Interestingly, C. neoformans utilizes 
S2P to cleave and activate SREBP like mammalian cells (Bien et al., 2009). Collectively, 
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this bioinformatic analysis identified a conserved glycine-leucine motif present in 
ascomycete fungi that lack S2P, further supporting a role for this sequence in SREBP 
cleavage. 
 
Sre1 cleavage requires glycine-leucine motif 
Having identified this conserved glycine-leucine motif, we next tested whether 
motif function is conserved between SREBPs. Fission yeast strains were generated that 
expressed wild-type or sre1 glycine-leucine motif mutants at the heterologous his3 locus 
(Burke and Gould, 1994). We cultured cells under low oxygen and assayed Sre1 cleavage 
by immunoblotting. Wild-type Sre1 precursor was cleaved to generate active Sre1N 
under hypoxia (upper, middle and lower panels of Figure 2.6B, lanes 1-4). Induction of 
Sre1 expressed from the his3 locus was reduced compared to wild-type cells, perhaps due 
to the absence of DNA elements required for key positive feedback regulation (Hughes et 
al., 2005; Lee et al., 2011; Porter et al., 2012). As a control, we tested mutation of Sre1 
N408E in the 7-amino-acid conserved motif, corresponding to the second position in the 
motif that was not required for cleavage of Sre2 (a.a. 679) (Figure 2.6A). In agreement, 
mutation of this residue did not affect cleavage of Sre1 (upper panel of Figure 2.6B, lanes 
5-8). Then, we tested 4 of 5 required residues in the motif for Sre1 cleavage. Notably, 
mutation of glycine at the third position (G409), methionine at the fourth position 
(M410), glycine at the sixth position (G412) and leucine at the seventh position (G413) 
blocked Sre1 cleavage under low oxygen (middle and lower panels of Figure 2.6B, lanes 
5-12). These results were consistent with Sre2-MS, showing cleavage defects at the third, 
fourth, sixth and seventh positions of the motif (Sre2 a.a. 678, 680, 683 and 684) (Figure 
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2.6A). As expected, deletion of the E3 ligase dsc1 abolished Sre1 cleavage (middle panel 
of Figure 2.6B, lane 13). In these experiments, the cleavage machinery functioned 
normally insomuch as endogenous Sre2 cleavage was normal (data not shown).  
As an independent test, we assayed the ability of these sre1 mutants to grow in the 
presence of cobalt chloride, a hypoxia mimetic (Lee et al., 2007; Stewart et al., 2011). 
Wild-type cells, but not sre1Δ cells, grow under low oxygen (Hughes et al., 2005). If 
Sre1 mutants are cleavage-defective, we expect to observe reduced growth on cobalt 
chloride, reminiscent of growth defects in sre1Δ and dsc1Δ  cells. Consistent with results 
from the cleavage assays in Figure 2.6B, Sre1 mutants blocked for cleavage failed to 
support wild-type growth on cobalt chloride (Figure 2.6C), and growth defects correlated 
with the severity of observed Sre1 cleavage defects (Figure 2.6B). These results 
demonstrate that the glycine-leucine motif is required for Sre1 cleavage, and together 
with the bioinformatic data suggest that this motif has a conserved function in SREBP 












Genetic studies revealed requirements for dsc1 through dsc6 in the cleavage 
activation of the yeast SREBP transcription factors Sre1 and Sre2 (Stewart et al., 2012; 
Stewart et al., 2011). Dsc1 through Dsc5 constitute the Dsc E3 ligase, a stable Golgi 
membrane complex containing the RING-domain E3 ubiquitin ligase Dsc1 (Stewart et 
al., 2012). dsc6 codes for Cdc48, an AAA-ATPase that binds to the Dsc E3 ligase 
through the ubiquitin regulatory X (UBX) domain of Dsc5 (Stewart et al., 2012). 
Previous studies indicate that the mechanism of cleavage is the same for Sre1 and Sre2 
(Stewart et al., 2012; Stewart et al., 2011), except that ER exit of Sre1 is regulated by 
sterols and oxygen and Sre2 exits the ER constitutively (Hughes et al., 2005; Porter et al., 
2012). Our working model for yeast SREBP (Sre1 and Sre2) cleavage is as follows: (1) 
SREBP moves from the ER to Golgi; (2) SREBP binds to the Dsc E3 ligase; (3) SREBP 
is ubiquitinated by the E2 ubiquitin-conjugating enzyme Ubc4 and E3 ligase Dsc1; (4) 
SREBP is subsequently cleaved by an unidentified protease releasing the N-terminal 
transcription factor domain from the membrane.  
To develop tools that will allow us to test this model and dissect the mechanism 
of SREBP cleavage, we investigated the structural requirements for SREBP cleavage. We 
focused initially on Sre2 because its cleavage is constitutive, allowing us to study 
sequences required for cleavage under routine cell culture conditions, rather than having 
to induce cleavage under hypoxia. Truncation analysis revealed that Sre2 cleavage does 
not require its bHLH-zip domain and demonstrated that a minimal substrate of 271 amino 
acids is still cleaved (Figure 1). This result indicates that the functions of Sre2 as a 
transcription factor and a substrate for Dsc-dependent cleavage are separable. Using a 
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truncated Sre2 model substrate, we identified 15 residues required for cleavage of full-
length Sre2 and uncovered a novel SREBP cleavage motif. We discuss these mutants in 
light of our current understanding of SREBP cleavage in S. pombe and mammals. 
Mutants blocked for Sre2 cleavage could be defective in any of the 4 steps outlined in our 
working model for SREBP cleavage. Sre2 cytosolic mutations could disrupt binding to 
COPII proteins required for sorting into vesicles and ER exit (Barlowe et al., 1994). 
However, none of the 15 Sre2 mutants localized to the ER when tested in either the GFP-
Sre2 (Figure 2.5C) or GFP-Sre2-MS localization studies (data not shown), suggesting 
that ER exit is normal in the mutants. In addition, Sre2 mutants showed wild-type 
expression (Figure 4B and 2.4C), suggesting that the proteins are properly folded and 
unlikely to be substrates for ER retention and endoplasmic-reticulum associated 
degradation (Hughes et al., 2009). Determinants required for ER exit may be located 
between a.a. 523-676, a region required for cleavage (Figure 1B), but not subjected to 
site-directed mutagenesis.   
 
Function of conserved glycine-leucine motif in SREBP cleavage 
Several lines of evidence suggest that the glycine-leucine motif is a key 
determinant for Dsc-dependent SREBP cleavage. First, the glycine-leucine motif is 
located at a conserved distance from the first transmembrane segment of Sre1 and Sre2 in 
S. pombe and more than 20 other ascomycete SREBPs. Second, the presence of the 
glycine-leucine motif correlates with the lack of Site-2 protease homologs, i.e. every 
ascomycete fungus that contains the conserved glycine-leucine motif lacks a Site-2 
protease homolog (Bien and Espenshade, 2010). Third, the glycine-leucine motif is 
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functionally required for both Sre1 and Sre2 cleavage in S. pombe. Fourth, this motif is 
broadly conserved among ascomycete fungi.  
Protein secondary structure software predicts this novel glycine-leucine motif 
folds either as alpha helix or beta strand. This motif might represent a hydrophobic 
interface for interaction with the Dsc E3 ligase or the unidentified fungal SREBP 
protease. Given that the motif is located at a distance (~20 amino acids) from the 
cleavage site, it is unlikely to participate in interactions with the protease active site. 
Indeed, a definitive functional assignment for this motif requires the development of 
additional assays for Dsc E3 ligase recognition, SREBP ubiquitination, and SREBP 
proteolytic cleavage.  
As noted, the protease that cleaves SREBP in this system is not known. 
Mammalian SREBP is cleaved sequentially by the Site-1 protease after RXXL in the ER 
lumenal loop, before it can be cleaved by the Site-2 protease within TM1 to release 
functional transcription factor domain (Brown and Goldstein, 1999). Site-1 protease 
belongs to the subtilisin/kexin-like protease family, required for cleaving many 
proproteins to their active form (Seidah, 2011; Seidah et al., 1998). Interestingly, we have 
isolated a cleavage mutant in the ER lumenal loop of Sre2 at lysine 743. A charge-
conservative mutation from lysine to arginine blocks Sre2 cleavage (Figure 3). 
Subtilisin/kexin-like proteases typically cleave after lysine or arginine and dibasic 
sequences (Seidah, 2011; Seidah et al., 1998), as evidenced by normal SREBP cleavage 
in mammals for the same corresponding K to R mutation (Duncan et al., 1997). Further, 
in contrast to the cleavage of mammalian SREBP by Site-1 protease at a lumenal RXXL 
sequence, this sequence is not conserved in Sre2 (Duncan et al., 1997). More generally, 
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proteases in the subtilisin/kexin-like family cleave after the consensus R-X-(R/K)-R 
sequence, where X is any amino acid except cysteine (Steiner, 1998). Collectively, these 
data argue against a Site-1 protease-like cleavage for yeast SREBP. 
A Site-2 protease cleavage mechanism is also unlikely given the cytosolic 
cleavage sites of Sre1 (Stewart et al., 2011) and Sre2 (Figure 2A). Sre2 cleavage defects 
at methionine 704 and serine 705 represent cleavage mutants close to the cleavage site 
(Figure 2.3A). These mutants might interfere directly with interaction between Sre2 and 
the unidentified protease. Consistent with this, the presence of Site-2 protease correlates 
with cleavage within the membrane (Bien et al., 2009; Bien and Espenshade, 2010), 
while the absence of Site-2 protease correlates with cytosolic cleavage. Given the lack of 
Site-2 protease homologs in S. pombe and the broader ascomycete fungal phylum, and no 
detectable cleavage within TM1, a new cleavage mechanism might be employed for 
ascomycete SREBPs. 
Sre2 cleavage mutants are enriched in the second transmembrane segment (TM2) 
(Figure 2.3A), but a close examination of other SREBP TM2s did not reveal conserved 
sequences. Interestingly, ubiquitination and sorting of the Pep12 membrane protein into 
the multivesicular body required insertion of an aspartate residue into its transmembrane 
segment and Tul1, the S. cerevisiae homolog of the Dsc1 E3 ligase (Reggiori and 
Pelham, 2002). Thus, it is possible that charged residues in a transmembrane segment are 
a signal for substrate recognition. Sre2 cleavage mutants within TM2 that contain a polar 
residue, such as glutamate 755, might fail to be recognized by the Dsc1 E3 ligase through 
the same mechanism. 
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Identification of the fungal SREBP protease and further characterization of Dsc 
E3 ligase function will require development of new assays. Importantly, these mutants 
will aid the identification of the protease and future structure-function studies. For 
example, genetic suppression of Sre1 cleavage-defective mutants may uncover 
components required for different steps in the pathway.  
 
Implications for fungal pathogenesis 
Ascomycete fungal pathogens remain detrimental to human health and 
agriculture. For instance, Aspergillus fumigatus is a major cause of life-threatening 
infections in immunocompromised individuals (Latge, 1999). Notably, Aspergillus 
fumigatus SREBP homolog SrbA as well as Dsc E3 ligase homologs are required for 
pathogenesis (Willger et al., 2012; Willger et al., 2008). Interestingly, the glycine-leucine 
motif is conserved in Aspergillus. In terms of agriculture, the fungal rice blast pathogen 
Magnaporthe oryzae, which causes destructive rice diseases and crop losses worldwide 
(Wilson and Talbot, 2009), also contains a putative SREBP homolog and the cleavage 
motif. Thus, this motif may be required for SREBP cleavage activation across 
ascomycete fungal pathogens. Because many other pathogenic fungi contain an SREBP 
pathway and the conserved motif, this study provides insight into molecular 








We obtained yeast extract, peptone and agar from BD Biosciences; Edinburgh 
minimal medium (EMM) from MP Biomedical; oligonucleotides from Integrated DNA 
Technologies; alkaline phosphatase from Roche; HRP-conjugated, affinity purified 
donkey anti-rabbit and anti-mouse IgG from Jackson ImmunoResearch; prestained 
protein standards from Biorad. 
 
Strains and media 
Wild-type haploid S. pombe KGY425 and derived strains were grown to log 
phase at 30°C in YES medium (5 g/liter yeast extract plus 30 g/liter glucose and 
supplements, 225 mg/liter each of adenine, uracil, leucine, histidine, and lysine) or EMM 
plus supplements unless otherwise indicated. Yeast transformations were performed as 
previously described (Hughes et al., 2005). Strains used in this study were derived using 
standard genetic techniques and are described in Table 2.S3 (Bahler et al., 1998).  
 
Antibodies 
We obtained anti-FLAG M2 from Sigma. Antisera to Sre1 (a.a. 1-260) and Sre2 
(a.a. 1-426) polyclonal IgG generated against the cytosolic N-terminus of fission yeast 
Sre1 and Sre2 have been described previously (Hughes et al., 2005).  
 
Plasmids 
RCP90 and RCP92 encode truncated, N-terminal fragments of Sre2 (a.a. 423-697 
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and 423-712) under control of the constitutive cauliflower mosaic virus (CaMV) 
promoter derived from pSLF101 (Forsburg, 1993). These plasmids were constructed by 
mutation of the appropriate codons to stop codons using Quikchange II XL mutagenesis. 
pCaMV-3xFLAG truncation plasmids listed in Figure 1 were generated by truncation of 
the appropriate amino acids in Sre2 using Quikchange II XL mutagenesis.  
Sre1 integrating plasmid contains the sre1+ coding sequence flanked by 800bp of 
upstream genomic sequence and 500bp of downstream genomic sequence, with a his3+ 
marker for chromosomal reconstitution of histidine auxotrophy (Burke and Gould, 1994). 
Plasmids containing sre1 wild-type and mutants (pES219, RCP365-RCP369) were 
linearized with AscI and transformed into sre1∆ strain, and selected for on minimal 
medium lacking histidine to generate strains carrying integrated wild-type and mutant 
alleles of sre1 at the his3+ locus.  
 
Low oxygen cell culture 
For Sre1 hypoxic cleavage assays, cells growing exponentially in YES medium 
were collected by centrifugation. Oxygenated medium was removed by aspiration, and 
cells were resuspended in deoxygenated YES medium under anaerobic conditions inside 
a Ruskinn Invivo2 400 hypoxic workstation (Biotrace, Inc.). Anaerobic conditions were 
achieved in the workstation using 10% hydrogen gas balanced with nitrogen in the 
presence of palladium catalyst. YES medium was deoxygenated by preincubation for >24 
hr in the hypoxic workstation. After resuspension, cultures were agitated at 30°C, 




For Sre1 and Sre2 cleavage assays, whole cell lysates were prepared for 
immunoblotting analysis. Protein preparation and immunoblotting for S. pombe 
experiments were described previously (Hughes et al., 2005). For Sre1 and Sre2, whole 
cell lysates were extracted and treated with alkaline phosphatase as described previously 
(Hughes et al., 2005). For Sre2 model substrate, anti-FLAG M2 antibody was used to 
detect the precursor (P) and the cleaved N-terminal nuclear form (N). For Sre2-GFP, anti-
Sre2 polyclonal antibody was used to detect the precursor (P) and cleaved N-terminal 
nuclear form (N).  
 
Fluorescence microscopy 
A plasmid expressing GFP-sre2 from the thiamine repressible nmt* promoter 
(pAH230) was described previously (Stewart et al., 2011). Cleavage mutants were 
generated in this plasmid using Quikchange II XL mutagenesis. Live cells were imaged 
on 2% agarose pads using a Zeiss Axioskop microscope equipped with fluorescence and 
Nomarski optics (Zeiss). Images were captured using a Photometrics Cool Snap EZ CCD 
camera and IP Lab Spectrum software (Biovision Technologies, Inc.). 
 
Mutagenesis screen of Sre2 model substrate 
Sre2 model substrate was expressed from a plasmid containing a truncated form 
of Sre2 (a.a. 423-793), tagged with a 3xFLAG epitope at its N-terminus, under control of 
the constitutive CaMV promoter. pCaMV mutant plasmids listed in Table 2.1 and Figure 
3 were generated by mutation of the appropriate codons using Quikchange II XL 
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mutagenesis. In the model substrate, 94 amino acids at the distal end of Sre2 (a.a. 676-
793), which spans the conserved glycine-leucine motif and two transmembrane segments, 
were analyzed for cleavage. These mutants were first mutated in groups of doublets or 
triplets. For the mutants that demonstrated cleavage defects, individual residues were 
mutated from each group to analyze the contribution to Sre2 cleavage defect. Cleavage 
defects in model substrate were confirmed by generating the respective mutants in 
plasmids expressing full-length sre2-GFP under the control of the constitutive CaMV 
promoter, as well as GFP-sre2 expressed from the thiamine repressible promoter nmt* 
(and/or GFP-model substrate fusion protein driven by CaMV promoter). These plasmids 
were used for examining cleavage and localization, respectively.  
 
Bioinformatics 
Conservation of glycine-leucine motif of SREBPs was mined using a custom Perl 
script. In brief, SREBPs were isolated by protein sequence alignment using BLAST 
database version 2.2.25 downloaded from National Center for Biotechnology Information 
(NCBI). For each SREBP, coordinates of each transmembrane segment (TM) were 
predicted using TM-HMM software version 2.0, executed through a BioPerl module and 
confirmed with Phobius (Stajich et al., 2002). Only SREBPs that contained one or more 
predicted TM(s) were used for downstream analysis. To define the consensus glycine-
leucine conserved motif, a 50-amino-acid stretch centered 55 amino acids before the first 
predicted TM was isolated for each SREBP. For all the isolated 50-amino-acid 
sequences, sequence similarity search was performed to reveal the conserved glycine-
leucine motif. A sequence logo was generated using WebLogo 3 (Crooks et al., 2004).  
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Figure 2.1. Establishing the minimal Sre2 sequence required for cleavage.  
(A) Diagrams for serial truncations of Sre2. bHLH-zipper region (bHLH-zip) and 
predicted transmembrane domains are indicated by gray and black boxes, respectively. 
(B) Serial truncation analysis of Sre2. Western blot probed with anti-FLAG IgG of whole 
cell lysates. Wild-type or dsc1Δ cells carrying FLAG-tagged N-terminal truncations of 
Sre2 or empty vector (EV) were grown in minimal medium lacking leucine for 16 hours. 
FLAG epitope is appended at the N-terminus of truncated Sre2 to monitor cleavage. All 
strains are sre2Δ.  
  
Figure 2.2. Cleavage of Sre2 model substrate occurs in the cytosol and requires Dsc 
E3 ligase complex and E2 enzyme Ubc4.  
(A) Western blot probed with anti-FLAG IgG of lysates from sre2Δ cells expressing 
wild-type Sre2 model substrate (MS) (amino acids 423-793) (lane 4), empty vector (EV, 
lanes 1 or 7), or truncated versions of Sre2 (amino acids 423–697 or 423–712, lanes 2, 3, 
5, and 6). (B) Western blot probed with anti-FLAG IgG of lysates from wild-type and 
indicated deletion or mutant strains. Strains carrying plasmids expressing Sre2-MS were 
grown in minimal medium lacking leucine for 16 hours. (C) Western blot probed with 
anti-FLAG IgG of lysates from wild-type and ubc4-P61S. Cells were grown to 
exponential phase at 25oC and shifted to the non-permissive temperature of 36oC for the 
indicated times. P and N, precursor and cleaved nuclear forms, respectively. All strains 
are sre2Δ.  
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Figure 2.3. Mutagenesis screen of Sre2 model substrate reveals sequence 
requirements for cleavage.  
(A) Diagram of predicted membrane topology and mutant classification for Sre2 model 
substrate (amino acids 423-793). 94 amino acids tested in mutagenesis screen are 
enclosed in squares. From these residues, mutants showing a robust block in cleavage 
(P>N) are indicated in red, mutants showing cleavage defect (N≈P) are indicated in gray, 
and residues showing normal cleavage (N>P) are indicated in white. Amino acid residues 
of basic helix-loop-helix zipper domain (bHLH-zip) are enclosed in hexagons. (B) 
Western blot probed with anti-FLAG IgG of lysates from sre2∆ cells expressing the 
indicated wild-type or mutant Sre2 model substrate. Each mutant defines a category of 
observed cleavage efficiency. Asterisks denote non-specific cross-reactive bands.  
 
Figure 2.4. Glycine-leucine sequence is required for yeast SREBP cleavage.  
(A) Alignment of glycine-leucine sequence from Sre1 and Sre2 of Schizosaccharomyces 
pombe, and diagrams for Sre1 and Sre2. Numbers indicate respective amino acid 
positions of Sre1 and Sre2. Arrow indicates predicted cleavage site. Glycine-leucine 
sequence and predicted transmembrane domains are indicated by red and black boxes, 
respectively. (B) Western blot probed with anti-FLAG IgG of lysates from indicated 
sre2∆ strains expressing either wild-type Sre2 model substrate (MS) or glycine-leucine 
sequence mutants. (C) Western blot probed with anti-FLAG IgG of lysates from the 
indicated strains expressing either wild-type Sre2-MS or cleavage-defective mutants. P 
and N, precursor and cleaved nuclear forms, respectively. All strains are sre2Δ.  
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Figure 2.5. Mutants are defective for cleavage of full-length Sre2.  
(A) Western blot probed with anti-Sre2 IgG of lysates from the indicated sre2∆ strains 
expressing either full-length wild-type Sre2-GFP or glycine-leucine motif mutants. (B) 
Western blot probed with anti-Sre2 IgG of lysates from the indicated sre2∆ strains 
expressing either full-length wild-type Sre2-GFP or cleavage-defective mutants. P and N, 
precursor and cleaved nuclear forms of Sre2-GFP, respectively. (C) Indicated sre2∆ 
strains expressing either wild-type GFP-Sre2 or GFP-Sre2 mutant were grown in minimal 
medium lacking leucine and thiamine for 20 hours to induce expression, and imaged by 
fluorescence microscopy. 
 
Figure 2.6. Glycine-leucine motif is broadly conserved in fungi and functionally 
conserved in Sre1.  
(A) Consensus SREBP glycine-leucine motif in fungi. Consensus sequence logo was 
generated by aligning 50-amino-acid stretches that were isolated and centered at 55 
amino acids before the first predicted TM of fungal SREBPs (see Experimental 
Procedures for details). Residues required for Sre2 cleavage are boxed. (B) Western blot 
probed with anti-Sre1 IgG of lysates from the indicated full-length wild-type Sre1 and 
glycine-leucine motif mutants expressed from the chromosome. Cells were grown in rich 
medium for the indicated times in the absence of oxygen. Sre1 N408E is used as a 
control, corresponding to a residue with normal cleavage in Sre2. P and N, precursor and 
cleaved nuclear forms of Sre1, respectively. (C) Growth of wild-type, sre1∆, dsc1∆, and 
indicated sre1 mutants on YES rich medium containing 1.6 mM cobalt chloride. 5x and 
1x indicates 25,000 and 5,000 cells respectively. 
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Table 2.1 
Summary of Sre2 model substrate mutants screened 
Cleavage of Sre2 model substrate mutants 
Block (P>N) Partial  (P≈N) Normal (N>P) 
L678T N679E V677T 
G680E E685A V682T 
L681T T686A T691A/N692A 
G683E V687A/H688A G697A 
L684T M689A/L690A S699A 
M704A P693A R701A 
S705A D694A F702A/S703A 
K743R D695A V706A/L707A 
E755L S698A S710A/P711A 
S765L N700A S712A/L713A 
P767L P708A H714L/S715L 
D770L I709A R718L/F719L 
W771L M731L/H732L F726L 
R778A S751L C728L/F729L 

























































































  aCleavage efficiency varied between model substrates (MS): Sre2 MS and GFP Sre2 MS  
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Table 2.S2 
Sequence comparison of fungal SREBP glycine-leucine motifs derived from 
bioinformatics analysis 
 
Phylum Organism Motif 
Ascomycota 
Schizosaccharomyces pombe Sre1 LNGMVGL 
Schizosaccharomyces pombe Sre2 LNGLVGL 
Schizosaccharomyces japonicus Sre1 LGGMVGL 
Schizosaccharomyces japonicus Sre2 LGGLAGV 
Schizosaccharomyces cryophilus Sre2 LGSLAGL 
Schizosaccharomyces octosporus Sre2 LGGLAGL 
Aspergillus nidulans LGTLAGL 
Aspergillus fumigatus LGALAGL 
Aspergillus terreus LGALAGL 
Verticillium aboatrum VGSLAGL 
Neosartorya fischeri LGALAGL 
Glomerella graminicola VGSLAGL 
Gibberella zeae VGSLAGL 
Magnaporthe oryzae VGSLAGL 
Neurospora crassa VGSLAGL 
Candida albicans LGGMAAV 
Candida dubliniensis LGGMAAV 
Pichia angusta VGDRKGL 
Kluyveromyces lactis N/A 
Basidiomycota 
Cryptococcus neoformans N/A 
Malassezia globosa N/A 
Ustilago maydis  N/A 
Piriformospora indica  N/A 
Sporisorium reilianum  N/A 
Laccaria bicolor  N/A 
Puccinia graminis f. sp. tritici  N/A 
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Source 
Figure 





PEY1642 h- leu1-32 ura4-D18 ade6-M210 his3-D1 
Δdsc1::kanMX6 Δsre2::kanMX6 
This Study 1,2 
PEY1643 h- leu1-32 ura4-D18 ade6-M210 his3-D1 
Δdsc2::kanMX6 Δsre2::kanMX6 
This Study 2 
PEY1645 h- leu1-32 ura4-D18 ade6-M210 his3-D1 
Δdsc3::kanMX6 Δsre2::kanMX6 
This Study 2 
PEY1644 h- leu1-32 ura4-D18 ade6-M210 his3-D1 
Δdsc4::kanMX6 Δsre2::kanMX6 
This Study 2 
PEY1646 h- leu1-32 ura4-D18 ade6-M210 his3-D1 
Δdsc5::kanMX6 Δsre2::kanMX6 
This Study 2 
PEY993 h- leu1-32 ura4-D18 ade6-M210;smt0 
rpl42::cyhR(sP56Q);mat1m-cyhS/ PEM-2 P392 
cdc48-4::natMX6 
This Study 2 










PEY1647 h- leu1-32 ura4-D18 ade6-M210 his3-D1::sre1-
his3+ Δsre1::kanMX6 
This Study 6 
PEY1648 h- leu1-32 ura4-D18 ade6-M210 his3-D1::sre1 
G409E-his3+ Δsre1::kanMX6 
This Study 6 
PEY1649 h- leu1-32 ura4-D18 ade6-M210 his3-D1::sre1 
M410E-his3+ Δsre1::kanMX6 
This Study 6 
PEY1650 h- leu1-32 ura4-D18 ade6-M210 his3-D1::sre1 
G412E-his3+ Δsre1::kanMX6 
This Study 6 
PEY1651 h- leu1-32 ura4-D18 ade6-M210 his3-D1::sre1 
N408E-his3+ Δsre1::kanMX6 
This Study 6 
PEY1652 h- leu1-32 ura4-D18 ade6-M210 his3-D1::sre1 
L413T-his3+ Δsre1::kanMX6 
This Study 6 

















Mechanisms of SREBP C-terminal Degradation 
















Fission yeast SREBPs are proteolytically activated to release the functional N-
terminal transcription factor. However, the protease responsible for cleaving SREBP 
remains elusive. Monitoring the fate of SREBP C-terminus represents a useful vantage 
point to dissect the elusive yeast SREBP cleavage mechanism. In this chapter, I 
established Sre2-GFP as a model to study potential C-terminal regulation and degradation 
of fission yeast SREBPs. I demonstrated that Sre2 C-terminal fragments are degraded in a 
Dsc E3 ligase dependent manner. This degradation relies on the core subunits Dsc1 
through Dsc4, but not the UBX-domain protein Dsc5, the AAA-ATPase Cdc48, or the 
putative rhomboid protease Rbd2. Moreover, the degradation of these Sre2 C-terminal 
fragments requires the proteasome in a time-dependent manner. Finally, Dsc1 E3 
ubiquitin ligase-dependent degradation of Sre2 C-terminal fragments also does not 
require Rbd2. While the identities of the SREBP C-terminal fragments await further 
characterization, these results described mechanisms of C-terminal degradation of 
SREBPs through the core subunits of Dsc E3 ligase and the proteasome, and represents 
the first steps towards understanding Golgi membrane protein degradation by means of a 









Transcription factors can be released from the membrane by two major 
mechanisms: regulated intramembrane proteolysis (RIP) and regulated 
ubiquitin/proteasome-dependent processing (RUP) (Hoppe et al., 2001). In the case of 
RIP, proteases that are embedded in the membrane cleave substrate membrane proteins. 
For RUP, protein release from the membrane requires the ubiquitin-proteasome system 
(UPS). 
RIP requires one of the three classes of intramembrane proteases: site-2 protease, 
gamma-secretase, and rhomboid protease (Brown et al., 2000). Site-2 protease is a zinc 
metalloprotease responsible for cleaving and releasing SREBP from the membrane in 
mammalian cells (Rawson et al., 1997; Sakai et al., 1996). Gamma-secretase is 
responsible for the cleavage of amyloid beta-protein precursor APP implicated in 
Alzheimer’s disease (Selkoe, 1994). Rhomboid proteases are a class of universally 
conserved intramembrane serine proteases that cleave other transmembrane proteins, with 
E. coli Spitz and Drosophila epidermal growth factor (EGF) receptor as representative 
substrates (Lee et al., 2001; Urban and Dickey, 2011). 
RUP makes use of the ubiquitin/proteasome system to process cellular protein 
substrates. Protein substrates are marked by ubiquitin, and can either be mono- or 
polyubiqutinated (Hershko and Ciechanover, 1998). Polyubiqutinated substrates are 
destined for degradation by the 26S proteasome (Kim et al., 2011). Alternatively, RUP 
activates both soluble and membrane transcription factors in mammals and yeast (Rape 
and Jentsch, 2004). For NFkB, the production of active transcription factor, p50, from the 
precursor p105 protein requires the 26S proteasome (Palombella et al., 1994). The 
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budding yeast S. cerevisiae possesses two transcription factors/coactivators, Mga2p and 
Spt23p, requiring the ubiquitin-proteasome system for activation (Hoppe et al., 2000; 
Piwko and Jentsch, 2006; Rape and Jentsch, 2002). Most recently, Def1, a protein 
responsible for RNA polymerase II-dependent DNA damage response, is processed in 
response to transcription stress through ubiquitination and proteasome-dependent 
processing (Wilson et al., 2013). The processed Def1 fragment accumulates in the 
nucleus and binds to RNA polymerase II for triggering its degradation (Wilson et al., 
2013). 
In this chapter, I aimed to use C-terminal degradation of fission yeast SREBP to 
investigate how SREBPs are processed and to establish fission yeast SREBPs as 
physiological substrates for Golgi protein processing. Membrane-bound transcription 
factors have to be released through a regulated manner to control cell homeostasis. Since 
Site-2 protease is not conserved in fission yeast, what is the mechanism of cleavage in 
this system? Is fission yeast SREBP released through RIP or RUP? Even though the Dsc 
E3 ligase is required for yeast SREBP cleavage activation, no active proteases were 
identified through the initial genetic screens (Stewart et al., 2012; Stewart et al., 2011). 
Excitingly, recent work from our group identified a fission yeast rhomboid protease Rbd2 
as a candidate yeast SREBP protease through a high-throughput genetic experiment 
(unpublished observation, Diedre Ribbens and Adam Frost). This study aimed to further 
dissect the potential roles of RIP through this rhomboid protease, and RUP by the 
proteasome as candidate direct proteolytic mechanisms. This chapter provided important 




Using Sre2-GFP to monitor Sre2 C-terminal fate 
Sre2 is a 793 a.a. protein with two transmembrane segments (a.a. 714-737 and a.a. 
749-771) (Figure 3.1A). To track Sre2 cleavage, Sre2 antibody was generated against the 
N terminus of Sre2, allowing the detection of both the precursor form (P) and the cleaved 
nuclear form (N). To monitor the fate of Sre2 C-terminus, I inserted GFP at the C-
terminus of Sre2, allowing the detection of the C-terminus using GFP antibody. In 
addition, this also has the benefit of distinguishing Sre2 precursor from Sre2 N-terminal 
cleaved form (Figure 3.1A), thus allowing me to track both Sre2 N and C termini 
simultaneously. Importantly, Sre2-GFP allows detailed study of the degradation of Sre2 
C-terminus that is dependent upon the Dsc E3 ligase, which is genetically required for 
cleavage activation of Sre2 (Stewart et al., 2012; Stewart et al., 2011). 
 
Dsc1 E3 ligase-dependent degradation of Sre2 C-terminal fragments  
To investigate whether any Sre2 C-terminal products can be detected at steady 
state, I overexpressed Sre2-GFP in sre2Δ  cells (otherwise wild-type condition), and 
probed for any GFP-associated fragments. Sre2 C-terminal fragments were not detectable 
using GFP antibody, suggesting that it is degraded constantly at steady state (Figure 3.1B, 
lanes 1-6). However, in cells that were also deleted for the Dsc1 E3 ubiquitin ligase, in 
addition to Sre2 full length precursors, I saw a robust accumulation of two GFP-
associated fragments running between 25kDa and 37kDa (Figure 3.1B, lanes 7-10), 
suggesting that degradation of GFP-associated fragments required the Dsc1 E3 ubiquitin 
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ligase. (The lack of detectable signal in lane 11 of Figure 3.1B might indicate a particular 
yeast isolate with low protein expression.)  
To test whether any of the two bands represent a GFP fragment (~26.9 kDa), or 
GFP fragment attached to Sre2 C-terminus fragments post-cleavage, I generated protein 
size standards expressing GFP alone or various C-terminal truncations of GFP with Sre2 
C-terminus from a plasmid in sre2Δ  cells or dsc1Δ  sre2Δ  cells and compared their 
migration patterns with the two Dsc1 E3 ligase-dependent GFP-associated fragments 
(Figure 3.1B, lanes 7-10). Results from this line of experiments were difficult to interpret 
(data not shown), due to seemingly random differential degradation of C-terminal 
truncation constructs. As a further attempt to resolve these fragments, I also performed 
membrane fractionation of these C-terminal fragments, and these fragments all 
segregated in the membrane fraction for the different migrating protein species (data not 
shown).  
However, efforts from such studies suggest that the upper band is likely to 
represent a Sre2 C-terminal fragment attached to GFP due to its significantly higher 
molecular weight than GFP alone, while the lower band migrated close in molecular 
weight to GFP (~26.9 kDa). Taken together, the degradation of these two GFP 
immunoreactive bands is markedly dependent upon the Dsc1 E3 ligase. 
 
Degradation of Sre2 C-terminal fragments requires Dsc1 through Dsc4, but not 
Dsc5, Cdc48 or Rbd2 
Cleavage of Sre1 and Sre2 requires each of the subunits of the Golgi Dsc E3 
ligase complex Dsc1 through Dsc5, AAA-ATPase Cdc48, and the rhomboid protease 
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Rbd2 (Stewart et al., 2012; Stewart et al., 2011; unpublished observations, Diedre 
Ribbens). To investigate whether degradation requirements of Sre2 C-terminal fragments 
parallel those of Sre1 and Sre2 cleavage, I examined the degradation of the C-terminal 
fragments in cells lacking each of these components. I found that Dsc1 through Dsc4 
were strictly required for degradation of Sre2 C-terminal fragments (Figure 3.2, lanes 2-
5). In dsc5Δ cells, Sre2 C-terminal fragments were not detected (Figure 3.2, lane 6), 
consistent with partial requirement of dsc5 for the cleavage of Sre2 precursor (Stewart et 
al., 2012). cdc48-4 contains a mutation (E325K) that lies in the Walker B motif in the 
AAA-ATPase domain of Cdc48 (Stewart et al., 2012). In these cells, only a small portion 
of the lower migrating band is detected upon high but not low exposure times of Western 
blot, reflecting efficient degradation similar to wild-type cells (Figure 3.2, lane 1). In 
cells lacking the rhomboid protease Rbd2, Sre2 C-terminal fragments were also 
undetected. Further, these results also hold true using an Sre2-GFP plasmid based assay 
in the indicated deletion or mutant strains (data not shown). Collectively, these results 
indicate that the requirement for degradation of Sre2 C-terminal fragments require the 
core Dsc E3 ligase subunits Dsc1 through Dsc4, but not Dsc5, Cdc48 or Rbd2. 
 
Degradation of Sre2 C-terminal fragments requires the proteasome 
Because Sre2 C-terminal fragments are unstable in wild-type cells, I next sought 
to determine the mechanism by which the fragments are degraded. To test whether 
degradation of the C-terminal fragments in wild-type cells requires the proteasome, wild-
type cells were treated with the proteasome inhibitor for 1, 2, 3 or 4 hours and C-terminal 
fragments were probed using GFP antibody (Figure 3.3, lanes 1-5). Treatment with the 
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proteasome inhibitor bortezomib increased the protein levels of C-terminal fragments 
only after 1 hour treatment. (The increased protein level in Figure 3.1 lane 2 compared to 
lane 1 was consistent in a separate experiment analogous to Figure 3.1, lanes 1-5, for 
which proteins were assessed as equally loaded by beta-actin control). Interestingly, the 
dynamics of proteasome stabilization and the protein expression level were distinct for 
the “upper band” (closest to 37kDa), the “lower band” (closest to 25kDa), and an 
additional proteasome-dependent band closest to 20kDa. The “upper band” was stabilized 
maximally at steady state after 1 hour treatment with bortezomib and did not increase 
over additional time points (Figure 3.3, lanes 1-5). In wild-type cells, the proteasome-
dependent band that migrated closest to 20kDa follows similar dynamics to the upper 
band. This band likely represents a degradation product associated with the “upper band”. 
Also, the “upper band” was present at a much higher level than the “lower band” in the 
presence of bortezomib. The “lower band”, more accurately described as a closely 
migrating set of doublets, however, illustrated a time-dependent stabilization that was 
maximal at 4 hours. While these fragments had differential proteasome-dependent 
stabilization dynamics, I conclude that degradation of Sre2 C-terminal fragments is 
dependent upon the proteasome. 
In addition, to further probe whether the proteasome also regulates C-terminal 
degradation in the absence of Dsc1 E3 ligase, the same time course experiment was 
performed in dsc1Δ  cells. Besides the appearance of the additional proteasome-
dependent band (closest to 20kDa), there was no proteasome-dependent stabilization of 
any additional C-terminal fragments (Figure 3.3, lanes 6-10). These results indicate that 
Dsc1 E3 ubiquitin ligase-dependent C-terminal fragments are generated through 
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mechanisms of cleavage independent of proteasome activity, and raises the possibility 
that these fragments might represent protease cleavage products that are degraded in a 
Dsc E3 ligase complex-dependent manner. 
 
Dsc1 E3 ubiquitin ligase-dependent degradation of Sre2 C-terminal fragments does 
not require the rhomboid protease Rbd2 
To directly test whether the Dsc1 E3 ubiquitin ligase-dependent fragments are 
cleavage products of the rhomboid protease Rbd2, I performed epistasis testing to track 
Sre2 N and C termini in either single mutants dsc1Δ  and rbd2Δ  cells, or dsc1Δ rbd2Δ  
double mutant cells. The results from tracking the Sre2 N-terminus suggest that dsc1Δ  is 
epistatic to rbd2Δ  for Sre2 cleavage, assuming a biochemical pathway (Figure 3.4, lanes 
1-5, lower panel). C-terminal fragments were only present in dsc1Δ  cells (Figure 3.4, 
lane 2, upper panel) but not rbd2Δ  cells (Figure 3.4, lane 3, upper panel). If either one of 
the two the C-terminal fragments is/are indeed cleavage product(s) of Rbd2, I would 
expect the disappearance of one or both of the C-terminal fragments only in dsc1Δ rbd2Δ  
double mutant cells but not in dsc1Δ  cells. However, both C-terminal fragments were 
still present in dsc1Δ rbd2Δ  cells (Figure 3.4, lane 4, upper panel). These results also 
hold true in an Sre2-GFP plasmid based assay in the respective relevant genetic 
backgrounds (data not shown). Collectively, these results suggest that Dsc1 E3 ligase-






 For SREBP cleavage in either fungal or mammalian cells, the fate of the 
membrane-associated C-terminal fragment post-SREBP cleavage is largely unexplored. 
In this chapter, I monitored the C-terminal associated fragment(s) of the fission yeast 
SREBP Sre2 and identified potential mechanisms of Sre2 C-terminal degradation through 
the Dsc E3 ligase and the proteasome. 
Importantly, the identities of the Dsc E3 ligase complex-dependent Sre2 C-
terminal fragments await further characterization (Figures 3.1 and 3.2). It is worth noting 
that the molecular weight of GFP is estimated to be 26.9kDa, while the upper band 
migrates at a molecular weight significantly larger than 26.9kDa (closer to 37kDa, which 
represents potentially ~60-70 amino acids of Sre2 C-terminus post-cleavage event). 
Therefore, it is likely that the upper band represents a product that contains part of the 
Sre2 C-terminus after Sre2 cleavage. The lower band migrates closer in molecular weight 
to GFP alone. It is tempting to speculate that the prominence of the lower band compared 
to the upper band reflects that the lower band is more stable and that the C-terminus of 
Sre2 is trimmed off to a more stable product that is either GFP alone or a smaller C-
terminal Sre2 fragment. Since results from protein size standards or membrane 
fractionation experiments remain inconclusive, an immediate future direction will be to 
map the Sre2 cleavage site through protein sequencing or mass spectrometry analysis of 
both the N-terminal and C-terminal fragments in order to further resolve the identities of 
these degradation/cleavage fragments. 
I tested the genetic requirements for degradation of Sre2 C-terminal fragments. 
Such degradation requires Dsc1 through Dsc4, but not Dsc5, Cdc48 or the putative 
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rhomboid protease Rbd2 (Figure 3.2). This result is consistent with Sre2 cleavage 
requirements for the release of the soluble N-terminus from the membrane, requiring 
Dsc1 through Dsc4, while only partially requiring Dsc5 and other mutant alleles of 
Cdc48 (Stewart et al., 2012; Stewart et al., 2011). Consistent with biochemical data of the 
subunit architecture of the Dsc E3 ligase, Dsc1 through Dsc4 constitutes the core subunits 
of the multi-subunit Dsc E3 ligase, while Dsc5 and Cdc48 might play a more indirect 
biochemical or mechanistic role in Sre1 and Sre2 cleavage (Lloyd et al., 2013; Stewart et 
al., 2012).  
I also investigated mechanisms underlying the degradation of Sre2 C-terminal 
fragments. I found that in wild-type cells, the fragments are rapidly degraded by the 
proteasome in a time-dependent manner (Figure 3.3). However, in cells that lack Dsc1 E3 
ubiquitin ligase, the migrating patterns of the C-terminal fragments remained similar. 
These might suggest that the Dsc1 E3 ligase-dependent degradation products are 
terminal, i.e. the proteasome does not cleave SREBP to release a higher molecular weight 
or stabilized C-terminal product(s) upon inhibition of proteasome function. If the 
proteasome is the protease responsible for yeast SREBP cleavage, we might expect a 
larger C-terminal associated product at steady state. The lack of proteasome-dependent 
stabilization might lead us to speculate that the proteasome is not likely to be the sole 
proteolytic machinery responsible for cleaving SREBP precursors to release functional 
SREBPs in fission yeast, similar to the cleavage activation of Mga2 or Spt23 (Hoppe et 
al., 2000; Rape et al., 2001).  
Finally, Dsc1 E3 ubiquitin ligase-dependent Sre2 C-terminal fragment(s) 
degradation also does not rely on the putative fission yeast rhomboid protease Rbd2 
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(Figure 3.4). Currently, Rbd2 is shown to the genetically required for Sre1 and Sre2 
cleavage (unpublished observations), while whether Rbd2 is directly cleaving Sre2, and if 
so, the site and mechanism of cleavage remain elusive. Nonetheless, these experiments 
uncovered and described the potential C-terminal degradation of SREBPs through the 
core subunits of Dsc E3 ligase and the proteasome, and provide important insights for 





















We obtained yeast extract, peptone and agar from BD Biosciences; Edinburgh 
minimal medium (EMM) from MP Biomedical; oligonucleotides from Integrated DNA 
Technologies; alkaline phosphatase from Roche; bortezomib from LC Laboratories; 
HRP-conjugated, affinity purified donkey anti-rabbit and anti-mouse IgG from Jackson 
ImmunoResearch; prestained protein standards from Biorad. 
 
Strains and media 
Wild-type haploid S. pombe KGY425 and derived strains were grown to log 
phase at 30°C in YES medium (5 g/liter yeast extract plus 30 g/liter glucose and 
supplements, 225 mg/liter each of adenine, uracil, leucine, histidine, and lysine) or EMM 
plus supplements unless otherwise indicated. Yeast transformations were performed as 
previously described (Hughes et al., 2005). Strains used in this study were derived using 
standard genetic techniques (Bahler et al., 1998).  
 
Antibodies 
We obtained anti-GFP (a mixture of clones 7.1 and 13.1) from Roche. Antisera to 
Sre2 (a.a. 1-426) polyclonal IgG generated against the cytosolic N-terminus of fission 






RCP23 encodes Sre2-GFP (a.a. 1-1026) under control of the constitutive 
cauliflower mosaic virus (CaMV) promoter derived from pSLF101 (Forsburg, 1993). 
 
Cleavage assay 
For Sre2 cleavage assay, whole cell lysates were prepared for immunoblotting 
analysis. Protein preparation and immunoblotting for S. pombe experiments were 
described previously (Hughes et al., 2005). For Sre2, whole cell lysates were extracted 
and treated with alkaline phosphatase as described previously (Hughes et al., 2005). For 
Sre2-GFP, anti-Sre2 polyclonal antibody was used to detect the precursor (P) and cleaved 
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Figure 3.1   Dsc1 E3 ubiquitin ligase dependent degradation of Sre2 C-terminal 
fragments. 
(A) Schematic diagram of Sre2 and Sre2-GFP. Predicted transmembrane domains are 
indicated by black boxes. GFP is appended at the C-terminus of Sre2 to monitor its fate. 
Basic helix-loop-helix zipper domain (bHLH-zip) and GFP are indicated by gray boxes. 
(B) Western blot probed with anti-GFP IgG of lysates. Sre2-GFP is expressed under the 
control of CaMV promoter on a plasmid for the indicated strains. Multiple isolated are 
tested for each genotype as tested. Empty vector (EV) for wild-type is included as control 
for antibody specificity. All strains are sre2Δ.  
 
Figure 3.2   Degradation Of Sre2 C-terminal fragments requires Dsc1 through Dsc4 
but not Dsc5, Cdc48 or the rhomboid protease Rbd2. 
Western blot probed with anti-GFP and anti-Sre2 IgG of whole cell lysates for the 
indicated strains. GFP is attached to the Sre2 C-terminus at its endogenous locus for the 
wild-type and indicated deletion or mutant strains. P and N, precursor and cleaved 
nuclear forms, respectively. 
 
Figure 3.3   Time-dependent degradation of Sre2 C-terminal fragments by the 
proteasome. 
Western blot probed with anti-GFP and anti-Sre2 IgG of whole cell lysates. The 
proteasome inhibitor bortezomib (2 mM) is added to the cells at a time course of 0, 1, 2, 3 
or 4 hrs before they are harvested for protein analysis. Sre2-GFP is expressed from a 
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plasmid under the control of CaMV promoter for the indicated strains. Empty vector 
(EV) for wild-type and dsc1Δ is included as control for antibody specificity. All strains 
are sre2Δ. P and N, precursor and cleaved nuclear forms, respectively. 
 
Figure 3.4   Dsc1 E3 ubiquitin ligase-dependent degradation of Sre2 C-terminal 
fragments does not require the rhomboid protease Rbd2. 
Western blot probed with anti-GFP and anti-Sre2 IgG of whole cell lysates. GFP is 
attached to the Sre2 C-terminus at its endogenous locus for the wild-type and indicated 
































In my graduate work, I defined structural requirements for yeast SREBP cleavage 
(Cheung and Espenshade, 2013), and investigated degradation of Sre2 C-terminus to 
delineate the mechanism of fungal SREBP cleavage. Sre2 cleavage mutants isolated from 
my study may be blocked in the following cleavage steps (Figure 4.1): (1) Sre2 transport 
from the ER to Golgi; (2) Sre2 binding to any subunits of the Dsc E3 ligase; (3) Sre2 
ubiquitination by the E2 ubiquitin-conjugating enzyme Ubc4 and E3 ligase Dsc1. 
Alternatively, these mutants can also be defective in mechanistic steps involving other 
components of the pathway, such as the candidate protease putative rhomboid protease 
Rbd2 identified from our recent work, which facilitates release of the N-terminal 
transcription factor domain from the membrane.  
Furthermore, monitoring the Sre2 C-terminus and deciphering its degradation 
mechanisms provide further insight into modes of transcription factor cleavage and 
activation by regulated intramembrane proteolysis (RIP) through the rhomboid protease 
Rbd2 or regulated ubiquitin-proteasome proteolysis (RUP) by the proteasome. In sum, I 
have established the fission yeast SREBP Sre2 as an important physiological substrate in 
the post-ER compartments/Golgi apparatus for degradation and/or processing. These 
studies will further our understanding of the role of SREBPs in fungal virulence, and 
cellular oxygen and sterol homeostasis. Since SREBPs are required for fungal 
pathogenesis, chemical inhibitors can be developed to block this pathway. Therefore, 






Given genetic requirements of a multi-subunit Golgi Dsc E3 ligase for yeast 
SREBP activation, current efforts are directed towards understanding the mechanism of 
SREBP cleavage in this system. Protease components are lacking in the system thus far, 
besides a genetic requirement for the 26S proteasome for Sre1 cleavage (Stewart et al., 
2011), until the recent discovery of the rhomboid protease Rbd2 through high-throughput 
genetic studies from our laboratory.  
Mammalian and basidiomycete fungal mammalian SREBP cleavage require Site-
2 protease, while ascomycete fungal SREBP cleavage genetically requires the rhomboid 
protease and the proteasome. Site-2 protease is not present in all the ascomycete fungi 
examined, suggesting that different proteases might have co-evolved to release the 
functional SREBP transcription factor from the membrane in diverse evolutionary 
lineages. It will be interesting to see whether this theme holds true for other 
evolutionarily conserved membrane-bound transcription factors and proteases. 
Sre2 cleavage does not require its basic helix-loop-helix zipper transcription 
factor domain, and a minimal substrate of 271 amino acids is still cleaved. This result 
indicates that the functions of Sre2 as a transcription factor and a substrate for Dsc-
dependent cleavage are separable. Mutants blocked for Sre2 cleavage uncovered in this 
thesis were focused on Sre2 a.a. 673 – 793, from which I identified 15 residues required 
for cleavage of full-length Sre2 and uncovered a novel SREBP cleavage motif. 
Additional cleavage mutants and motifs may be located between a.a. 523 – 676, a region 
required for cleavage but not subjected to site-directed mutagenesis.   
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Future studies should focus on the following questions: (1) What is the SREBP 
protease? (i.e. Is yeast SREBP cleaved directly by the candidate rhomboid protease Rbd2 
by RIP and/or the proteasome by RUP?) Both careful in vitro and in vivo studies are 
needed to prove functional relevance and direct protease activity on the substrate. Further 
characterization of the in vivo cleavage sites of Sre2 and fate mapping studies of Sre2 C-
terminus in this thesis will also facilitate such dissection.  
(2) Does Dsc E3 ligase ubiquitinate yeast SREBPs? Thus far, we have been 
unable to detect stable mono- or polyubiquitinated SREBP species. Previous studies have 
captured a specific yet transient interaction between the Dsc2 subunit of the Dsc E3 
ligase and Sre2 (Stewart et al., 2011), suggesting that the E3 ligase-substrate interaction 
is not stable. Using an improved protein interaction assay to trap substrate interaction by 
blocking E2 ubiquitin-conjugating enzyme Ubc4 (unpublished result, Sumana 
Raychaudhuri), all the cleavage mutants uncovered in my screen are still able to bind to 
Dsc2 (unpublished results, data not shown). Indeed, more sensitive protein interaction 
assays needs to be developed under appropriate genetic backgrounds, or additional 
escorting factors or mechanistic steps await discovery. Alternatively, the Dsc E3 ligase 
does not act directly on SREBP. Intriguingly, my results on the degradation of Sre2 C-
terminal fragments suggest that the Sre2 C-terminus may be ubiquitinated and degraded 
in a proteasome and Dsc E3 ligase-dependent manner. Studies of Sre2 C-terminus 
represent fruitful avenues for future investigation. 
This leads to the third major question: (3) What are other Dsc substrates? Given 
that budding yeast contains functional Dsc component(s), but does not contain SREBPs 
(Bien and Espenshade, 2010), Dsc must have a role beyond SREBP cleavage. As a first 
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pass, other protein substrates in the fungal genomes that contain the fungal glycine-
leucine motif can be isolated using bioinformatic approaches and may warrant further 
investigation as candidate Dsc substrates (Cheung and Espenshade, 2013). Importantly, 
substrates that are differentially ubiquitinated by the Dsc E3 ligase may be identified by 
proteomic approaches (Lee et al., 2011).  
Precedence exists for post-ER protein degradation, but the molecular machinery 
remains largely unknown (Arvan et al., 2002). Given the functional parallels between 
ERAD protein quality control components and the Dsc E3 ligase components, Dsc E3 
ligase is a candidate machinery for Golgi protein quality control. Future studies of Dsc 
E3 ligase-dependent SREBP processing will provide important insights into Golgi protein 
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Figure 4.1  Mechanistic steps at which cleavage mutants may be defective in fission 
yeast SREBP cleavage. 
 
Major mechanistic steps at which cleavage mutants can be blocked are denoted 
numerically in the schematic: (1) transport from endoplasmic reticulum to Golgi; (2) 
interaction with each of the subunits of the Golgi Dsc E3 ligase; and (3) subsequent 
ubiquitination of SREBPs by the Dsc E3 ligase. Alternatively, the mutants can block 
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